NIHR Biomedical Research Centre at Moorfields Eye Hospital and UCL Institute of Ophthalmology, London, UK.
London School of Hygiene and Tropical Medicine, London, UK.
Eye (Lond). 2020 Jan;34(1):161-167. doi: 10.1038/s41433-019-0687-5. Epub 2019 Dec 3.
Evidence for the effectiveness of interventions to prevent the progression of optic nerve damage in open angle glaucoma has evolved over the last 25 years. We describe that evolution through the systematic reviews on various aspects of the topic and how those reviews have highlighted the need for new trials. Though we can be confident that lowering pressure does indeed reduce the risk of progression, we still lack good evidence on the comparative effectiveness of different treatments not so much on lowering pressure but on preventing progression of the disease. This is true for different medicines, types of laser and especially for different surgical interventions. As always there is a need for more research, but this needs to be focussed on key uncertainties using core outcome sets which avoid research waste. Ultimately, our guidelines can be based on sound and comprehensive evidence of effectiveness.
在过去的 25 年中,已经有证据表明干预措施可以有效预防开角型青光眼视神经损伤的进展。我们通过对该主题各个方面的系统评价来描述这一演变过程,以及这些评价如何突出了开展新试验的必要性。虽然我们可以确信降低眼压确实可以降低进展的风险,但我们仍然缺乏关于不同治疗方法的比较效果的良好证据,这些治疗方法不仅可以降低眼压,还可以预防疾病的进展。不同的药物、激光类型,尤其是不同的手术干预措施都是如此。正如以往一样,需要进行更多的研究,但这项研究需要使用核心结局集来集中解决关键的不确定性问题,以避免研究浪费。最终,我们的指南可以基于有效性的可靠和全面证据。